Glucomet Plus Tablets
Glucomet Plus Tablets combine Glibenclamide and Metformin Hydrochloride for comprehensive type 2 diabetes management. • Glibenclamide (sulfonylurea) stimulates pancreatic insulin secretion — highest hypoglycaemia risk in its class. • Metformin (biguanide) lowers hepatic glucose production and improves peripheral insulin sensitivity. Strictly Rx — must not be used in type 1 diabetes, severe kidney, or liver disease.
Pay in 3 Installments of
Rs.
151
Glucomet Plus Tablets
Description
About Glucomet Plus Tablets
Glucomet Plus Tablets are a prescription combination of Glibenclamide (sulfonylurea) and Metformin Hydrochloride (biguanide), formulated for adults whose type 2 diabetes is inadequately controlled by diet, exercise, or single-agent therapy. Glibenclamide stimulates pancreatic beta cells to release insulin; Metformin lowers hepatic glucose output, decreases intestinal glucose absorption, and enhances peripheral insulin sensitivity — a complementary dual mechanism that reduces both fasting and postprandial blood glucose.
Important safety note: Glibenclamide carries the highest hypoglycaemia risk among sulfonylureas. Patients must not skip meals, should monitor blood glucose regularly, and should carry a fast-acting glucose source. Strictly Rx — a valid prescription is required. Contraindicated in type 1 diabetes, severe renal or hepatic impairment, and pregnancy. Long-term therapy requires periodic renal function monitoring.
See our general medicines collection or browse all tablets and capsules available with COD delivery across Pakistan.
Key Benefits
- Dual glycaemic control: stimulates insulin secretion and reduces hepatic glucose production
- Lowers fasting and after-meal blood sugar effectively
- Reduces risk of diabetic complications with long-term controlled use
- Metformin component supports weight-neutral therapy
- Convenient combined tablet for patients on dual oral therapy
How to Use
- Follow your doctor's prescription exactly — dose and timing are individualised.
- Take with or immediately after a meal to minimise GI effects and hypoglycaemia risk.
- Take at the same time daily for stable blood glucose control.
- Monitor blood glucose and renal function periodically as advised by your physician.
Frequently Asked Questions
- Q: What conditions is Glucomet Plus prescribed for?
- A: It is indicated for type 2 diabetes mellitus when diet, exercise, or single oral antidiabetic therapy is insufficient.
- Q: How severe is the hypoglycaemia risk?
- A: Glibenclamide has the strongest hypoglycaemic effect among sulfonylureas. Missed meals, strenuous exercise, or alcohol significantly raise this risk. Always have glucose readily available.
- Q: Is Glucomet Plus suitable for elderly patients?
- A: Glibenclamide is generally not preferred in elderly patients due to the heightened risk of prolonged hypoglycaemia. A doctor should assess the risk-benefit carefully.
Usage & Benefits
- Dual glycaemic control: targets both insulin secretion and hepatic glucose output
- Reduces fasting and after-meal blood sugar levels effectively
- Lowers long-term diabetic complication risk with sustained glycaemic control
- Metformin supports weight-neutral diabetes therapy
- Replaces two separate tablets with one convenient combination
How To Use
1. Follow your doctor's prescription exactly — dose and timing are individualised.
2. Take with or immediately after a meal to reduce GI effects and hypoglycaemia risk.
3. Maintain consistent daily timing for stable glucose control.
4. Monitor blood glucose and renal function periodically as medically directed.
FAQs
What conditions is Glucomet Plus prescribed for?
Type 2 diabetes mellitus when diet, exercise, or single oral antidiabetic therapy is inadequate.
How severe is the hypoglycaemia risk?
Glibenclamide has the strongest hypoglycaemic effect among sulfonylureas. Missed meals, strenuous exercise, or alcohol raise this risk significantly — always carry glucose.
Is Glucomet Plus suitable for elderly patients?
Generally not preferred in the elderly due to prolonged hypoglycaemia risk from Glibenclamide. A physician must assess risk-benefit carefully.
Dermatologist Recommended
Healer's Pharma Minoxidil 5% + Finasteride 0.25% Hair Regrowth Spray
0.25% Finasteride Topical Hair Loss Spray by Healer's Pharma
